insights_auto
Why is BOT down 5,26%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,018 A$
arrow_downward
-5,26%(-0,0010) 1D
2 հոկ, 10:36:33 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
44,74 մլն
Avg. vol.
6,30 մլն
Volume
488,13 հզր
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
44,74 մլն
Avg. vol.
6,30 մլն
Volume
488,13 հզր
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
Reuters
·
43 րոպե առաջ
Australia's Sunrise Energy Metals plans US redomicile, primary Nasdaq listing
WTAQ
·
1 ժամ առաջ
Moderna to join Nasdaq 100, replacing Warner Bros Discovery
The Globe and Mail
·
28 րոպե առաջ
Kaplan Fox Encourages Investors of Fluence Energy, Inc. (NASDAQ: FLNC) to Contact the Firm to Learn About Their Legal Rights
MarketWatch
·
4 ժամ առաջ
The stock market is anything but normal right now — and these charts show it
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd